serw-MX  [xml]  
 


    
 DeCS Categories

A11 Cells .
A11.329 Connective Tissue Cells .
A11.329.372 Macrophages .
A11.329.372.700 Osteoclasts .
A11.627 Myeloid Cells .
A11.627.482 Macrophages .
A11.627.482.700 Osteoclasts .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.276 Intercellular Signaling Peptides and Proteins .
D12.644.276.374 Cytokines .
D12.644.276.374.465 Interleukins .
D12.644.276.374.465.511 Interleukin-11 .
D12.776 Proteins .
D12.776.467 Intercellular Signaling Peptides and Proteins .
D12.776.467.374 Cytokines .
D12.776.467.374.465 Interleukins .
D12.776.467.374.465.511 Interleukin-11 .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.705 Receptors, Immunologic .
D12.776.543.750.705.852 Receptors, Cytokine .
D12.776.543.750.705.852.760 Receptors, Tumor Necrosis Factor .
D12.776.543.750.705.852.760.949 Tumor Necrosis Factor Decoy Receptors .
D12.776.543.750.705.852.760.949.249 Osteoprotegerin .
D23 Biological Factors .
D23.529 Intercellular Signaling Peptides and Proteins .
D23.529.374 Cytokines .
D23.529.374.465 Interleukins .
D23.529.374.465.511 Interleukin-11 .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.377 Growth Substances .
D27.505.696.377.077 Angiogenesis Modulating Agents .
D27.505.696.377.077.099 Angiogenesis Inhibitors .
D27.505.696.377.450 Growth Inhibitors .
D27.505.696.377.450.100 Angiogenesis Inhibitors .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.025 Angiogenesis Inhibitors .
G07 Physiological Phenomena .
G07.345 Growth and Development .
G07.345.500 Morphogenesis .
G07.345.500.325 Embryonic and Fetal Development .
G07.345.500.325.377 Organogenesis .
G07.345.500.325.377.625 Musculoskeletal Development .
G07.345.500.325.377.625.100 Bone Development .
G07.345.500.325.377.625.100.729 Osteogenesis .
G11 Musculoskeletal and Neural Physiological Phenomena .
G11.427 Musculoskeletal Physiological Phenomena .
G11.427.578 Musculoskeletal Development .
G11.427.578.100 Bone Development .
G11.427.578.100.729 Osteogenesis .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Osteoprotegerin .
FDCR-1 Protein .
Follicular Dendritic Cell-Derived Receptor-1 .
OCIF Protein .
Tumor Necrosis Factor Receptor 11b .
FDCR 1 Protein .
Follicular Dendritic Cell Derived Receptor 1 .
Osteoclastogenesis Inhibitory Factor .
Receptors, Tumor Necrosis Factor, Member 11b .
Tumor Necrosis Factor Receptor Superfamily, Member 11b .
A secreted member of the TNF receptor superfamily that negatively regulates osteoclastogenesis. It is a soluble decoy receptor of RANK LIGAND that inhibits both CELL DIFFERENTIATION and function of OSTEOCLASTS by inhibiting the interaction between RANK LIGAND and RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B. .
1.00
414035
 
Osteogenesis .
Endochondral Ossification .
Ossification .
Ossification, Physiological .
Osteoclastogenesis .
Physiologic Ossification .
Endochondral Ossifications .
Ossification, Endochondral .
Ossifications .
Ossifications, Endochondral .
Osteoclastogeneses .
Physiological Ossification .
Bone Formation .
Ossification, Physiologic .
The process of bone formation. Histogenesis of bone including ossification. .
0.71
 
Interleukin-11 .
IL11 18793 .
Factor, Adipogenesis Inhibitory .
Inhibitory Factor, Adipogenesis .
Interleukin 11 .
Adipogenesis Inhibitory Factor .
IL-11 .
A lymphohematopoietic cytokine that plays a role in regulating the proliferation of ERYTHROID PRECURSOR CELLS. It induces maturation of MEGAKARYOCYTES which results in increased production of BLOOD PLATELETS. Interleukin-11 was also initially described as an inhibitor of ADIPOGENESIS of cultured preadipocytes. .
0.63
21181
 
Angiogenesis Inhibitors .
Angiogenesis Factor Inhibitors .
Angiogenetic Antagonists .
Angiogenetic Inhibitors .
Angiogenic Inhibitors .
Antagonists, Angiogenic .
Anti-Angiogenesis Effect .
Anti-Angiogenesis Effects .
Anti-Angiogenetic Agents .
Antiangiogenesis Effect .
Antiangiogenesis Effects .
Antiangiogenic Agents .
Inhibitors, Angiogenesis .
Inhibitors, Angiogenetic .
Inhibitors, Angiogenic .
Inhibitors, Neovascularization .
Agents, Angiostatic .
Agents, Anti-Angiogenetic .
Agents, Antiangiogenic .
Antagonists, Angiogenetic .
Anti Angiogenesis Effect .
Anti Angiogenesis Effects .
Anti Angiogenetic Agents .
Anti Angiogenic Drugs .
Drugs, Anti-Angiogenic .
Effect, Anti-Angiogenesis .
Effect, Antiangiogenesis .
Effects, Anti-Angiogenesis .
Effects, Antiangiogenesis .
Factor Inhibitors, Angiogenesis .
Inhibitors, Angiogenesis Factor .
Angiogenic Antagonists .
Angiostatic Agents .
Anti-Angiogenic Drugs .
Neovascularization Inhibitors .
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. .
0.59
16121375
 
Osteoclasts .
Cementoclast .
Cementoclasts .
Odontoclast .
Osteoclast .
Odontoclasts .
A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. .
0.57
11314386